Shareholders have rejected Florenz’s takeover offer, and Bougen is still talking of putting a recapitalisation plan before the board.
Probiotics seller says drop in ingredients segment sales drove result.
Joint supplement turned retirement company wants to carve niche serving higher-needs residents.
Walsh will sell off some of his shares.
The hospitality business has just settled a $2m private placement.
Fledgling Kiwi company sees itself as consolidator for global market.
New boss axed 55 jobs at end of last year in $8m cost savings bid.
CEO Simon Mander says Covid is muddying company's prospects at present.
The NZX-listed honey, skincare, and supplements company has written down its newly-acquired honey business.
Company’s 12 dealerships restricted from fully operating for 108 days.